Published on in Vol 9, No 4 (2020): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15646, first published .
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

Journals

  1. Xie Y, Baker J, Young T, Jun M, Sukkar L, Campain A, Kang A, Cass A, Hu J, Peiris D, Pollock C, Wong G, Zoungas S, Rogers K, Jardine M, Hockham C, Chow C, Comino E, Foote C, Gallagher M, Knight J, McNamara M, Liu B, Lung T, Sullivan D, Wilson R. Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis. Diabetes Care 2020;43(11):e185 View
  2. Zhang H, Rogers K, Sukkar L, Jun M, Kang A, Young T, Campain A, Cass A, Chow C, Comino E, Foote C, Gallagher M, Knight J, Liu B, Lung T, McNamara M, Peiris D, Pollock C, Sullivan D, Wong G, Zoungas S, Jardine M, Hockham C. Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data. Journal of Clinical & Translational Endocrinology 2020;22:100240 View
  3. Rush A, Sutherland G. The future of brain banking in Australia: an integrated brain and body biolibrary. Medical Journal of Australia 2021;214(10):447 View
  4. Jun M, Scaria A, Andrade J, Badve S, Birks P, Bota S, Campain A, Djurdjev O, Garg A, Ha J, Harel Z, Hemmelgarn B, Hockham C, James M, Jardine M, Levin A, McArthur E, Ravani P, Shao S, Sood M, Tan Z, Tangri N, Whitlock R, Gallagher M. Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study. European Heart Journal - Quality of Care and Clinical Outcomes 2023;9(6):621 View
  5. Kang A, Sukkar L, Hockham C, Jun M, Young T, Scaria A, Foote C, Neuen B, Cass A, Pollock C, Comino E, Lung T, Pecoits‐Filho R, Rogers K, Jardine M. Risk factors for incident kidney disease in older adults: an Australian prospective population‐based study. Internal Medicine Journal 2022;52(5):808 View
  6. Bleicher K, Summerhayes R, Baynes S, Swarbrick M, Navin Cristina T, Luc H, Dawson G, Cowle A, Dolja-Gore X, McNamara M. Cohort Profile Update: The 45 and Up Study. International Journal of Epidemiology 2023;52(1):e92 View
  7. Campain A, Hockham C, Sukkar L, Rogers K, Chow C, Lung T, Jun M, Pollock C, Cass A, Sullivan D, Comino E, Peiris D, Jardine M. Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction. Frontiers in Pharmacology 2022;13 View
  8. Ha J, Scaria A, Andrade J, Badve S, Birks P, Bota S, Campain A, Djurdjev O, Garg A, Harel Z, Hemmelgarn B, Hockham C, James M, Jardine M, Lam D, Levin A, McArthur E, Ravani P, Shao S, Sood M, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M. Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada. Kidney Medicine 2023;5(7):100675 View
  9. Young T, Hockham C, Sukkar L, Kang A, Jun M, Foote C, Baker J, Rogers K, Zoungas S, Cass A, Sullivan D, Jardine M. Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study. Endocrine and Metabolic Science 2023;12:100135 View